State of New Jersey Common Pension Fund D’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$693K Buy
9,933
+1,645
+20% +$120K ﹤0.01% 1597
2026
Q1
$596K Buy
+8,288
New +$472K ﹤0.01% 1441
2022
Q4
Sell
-34,394
Closed -$1.65M 1724
2022
Q3
$1.65M Sell
34,394
-4,639
-12% -$276K 0.01% 1607
2022
Q2
$2.23M Buy
39,033
+23,165
+146% +$1.46M 0.01% 1258
2022
Q1
$1.28M Hold
15,868
﹤0.01% 1651
2021
Q4
$3.22M Buy
15,868
+2,439
+18% +$529K 0.01% 985
2021
Q3
$3.62M Buy
13,429
+4,286
+47% +$1.03M 0.01% 904
2021
Q2
$2.35M Buy
9,143
+1,381
+18% +$382K 0.01% 1561
2021
Q1
$2.33M Sell
7,762
-690
-8% -$215K 0.01% 1443
2020
Q4
$2.15M Buy
8,452
+79
+0.9% +$20.4K 0.01% 1471
2020
Q3
$2.08M Buy
8,373
+312
+4% +$98.1K 0.01% 1316
2020
Q2
$2.8M Sell
8,061
-424
-5% -$132K 0.01% 924
2020
Q1
$2.27M Hold
8,485
0.01% 933
2019
Q4
$2.75M Sell
8,485
-402
-5% -$117K 0.01% 1090
2019
Q3
$2.43M Sell
8,887
-27,113
-75% -$9.94M 0.01% 1207
2019
Q2
$19.2M Hold
36,000
0.07% 294
2019
Q1
$18.1M Buy
36,000
+1,000
+3% +$593K 0.07% 302
2018
Q4
$17.3M Buy
35,000
+28,000
+400% +$16.9M 0.07% 284
2018
Q3
$6.4M Hold
7,000
0.02% 537
2018
Q2
$5.13M Hold
7,000
0.02% 588
2018
Q1
$11.2M Hold
7,000
0.04% 394
2017
Q4
$6.27M Hold
7,000
0.02% 528
2017
Q3
$2.52M Hold
7,000
0.01% 709
2017
Q2
$2.05M Hold
7,000
0.01% 729
2017
Q1
$2.46M Hold
7,000
0.01% 692
2016
Q4
$1.29M Hold
7,000
0.01% 799
2016
Q3
$1.8M Hold
7,000
0.01% 743
2016
Q2
$1.49M Hold
7,000
0.01% 757
2016
Q1
$1.44M Hold
7,000
0.01% 759
2015
Q4
$1.77M Hold
7,000
0.01% 756
2015
Q3
$1.15M Hold
7,000
﹤0.01% 827
2015
Q2
$1.31M Hold
7,000
0.01% 817
2015
Q1
$1.16M Hold
7,000
﹤0.01% 839
2014
Q4
$1.63M Hold
7,000
0.01% 813
2014
Q3
$1.27M Hold
7,000
0.01% 802
2014
Q2
$1.35M Buy
+7,000
New +$1.24M 0.01% 788

Other funds holding NKTR

State of New Jersey Common Pension Fund D's NKTR Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Nektar Therapeutics (NKTR) stake by 20% in Q2 2026, buying an estimated $120K and bringing the position to 9,933 shares worth $693K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

State of New Jersey Common Pension Fund D first reported a position in NKTR in Q2 2014 and has held it in 36 quarters since. The position peaked at $19.2M in Q2 2019. 54 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 9,933 shares of Nektar Therapeutics worth $693K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 1,645 Nektar Therapeutics shares in Q2 2026, an estimated $120K.
  • Nektar Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1597 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Nektar Therapeutics in Q2 2014 and has held it in 36 quarters since.
  • State of New Jersey Common Pension Fund D's Nektar Therapeutics position peaked at $19.2M in Q2 2019.
  • 54 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.